Related references
Note: Only part of the references are listed.Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine
Valentin Van den Bossche et al.
DRUG RESISTANCE UPDATES (2022)
Lipogenesis inhibitors: therapeutic opportunities and challenges
Battsetseg Batchuluun et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
Kamal Eltayeb et al.
CELLS (2022)
Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Anne-Laure Desage et al.
FRONTIERS IN ONCOLOGY (2022)
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen et al.
DRUG RESISTANCE UPDATES (2022)
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka et al.
DRUG RESISTANCE UPDATES (2021)
Impact of cancer metabolism on therapy resistance - Clinical implications
Ana Cristina Goncalves et al.
DRUG RESISTANCE UPDATES (2021)
ACSL family: The regulatory mechanisms and therapeutic implications in cancer
Jing Quan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non-small cell lung cancer
Fuan Wang et al.
MOLECULAR MEDICINE REPORTS (2021)
The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction
Pavel Vodicka et al.
CANCERS (2021)
Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model
Hidenori Ando et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
Federica Lo Sardo et al.
CANCER LETTERS (2021)
Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice
Rui-Lin Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis
Khoa Pham et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)
Loss of wild type KRAS in KRASMUT lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors
Yan Liu et al.
LUNG CANCER (2021)
Metabolic Strategies for Inhibiting Cancer Development
Philippe Icard et al.
ADVANCES IN NUTRITION (2021)
Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells
Sissel E. Dyrstad et al.
CANCERS (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions
Alexandre Vallee et al.
CANCERS (2021)
Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer
Xiaodan Sun et al.
JOURNAL OF ONCOLOGY (2021)
Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer
Chuncao Xu et al.
CELL DEATH DISCOVERY (2021)
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
Chao Dong et al.
FRONTIERS IN PHARMACOLOGY (2021)
New Therapeutic Strategies for Lung Cancer
Philippe Icard et al.
CANCERS (2021)
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling
Huiyan Zhen et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
Liu Liu et al.
CANCER SCIENCE (2021)
AMPKα loss promotes KRAS-mediated lung tumorigenesis
Manuela La Montagna et al.
CELL DEATH AND DIFFERENTIATION (2021)
Targeting GLS1 to cancer therapy through glutamine metabolism
Wei Yu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
KRAS Inhibitor Resistance in MET-Amplified KRASG12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms
Shinichiro Suzuki et al.
CLINICAL CANCER RESEARCH (2021)
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment
Yao-An Shen et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2021)
Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer
Zi-Xian Liao et al.
DRUG DISCOVERY TODAY (2021)
Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature
Severin K. Thompson et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
Philippe Icard et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer
Chunhua Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Gene of the month: STK11
Roman E. Zyla et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
Qian Wang et al.
HUMAN CELL (2021)
PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia
Han Koo et al.
CANCERS (2021)
PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
Nadiia Lypova et al.
CELLS (2021)
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway (vol 11, 642229, 2021)
Xuan Wei et al.
FRONTIERS IN ONCOLOGY (2021)
LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p
Gang Hua et al.
PHARMACOLOGY (2021)
Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
Blanca Majem et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation
Daisuke Hayakawa et al.
THORACIC CANCER (2020)
ATP citrate lyase: A central metabolic enzyme in cancer
Philippe Icard et al.
CANCER LETTERS (2020)
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Xin Cao et al.
DRUG RESISTANCE UPDATES (2020)
YAP/TAZ functions and their regulation at a glance
Arianna Pocaterra et al.
JOURNAL OF CELL SCIENCE (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)
Aaron C. Tan
THORACIC CANCER (2020)
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
Poorva Ghosh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PFKP is highly expressed in lung cancer and regulates glucose metabolism
Jianfei Shen et al.
CELLULAR ONCOLOGY (2020)
IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
Erika F. Rodriguez et al.
CANCER MEDICINE (2020)
The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung Cancer
Pei-Shan Hung et al.
CANCERS (2020)
Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities
Shuang Liu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
Michele Dal Bo et al.
DRUG RESISTANCE UPDATES (2020)
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)
Besa Emini Veseli et al.
FEBS LETTERS (2020)
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
Giovanna Li Petri et al.
BRITISH JOURNAL OF CANCER (2020)
Current therapy of KRAS-mutant lung cancer
Aron Ghimessy et al.
CANCER AND METASTASIS REVIEWS (2020)
Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment
Junnan Li et al.
CANCERS (2020)
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
Feng Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4-and HDAC5-mediated metabolic reprogramming
Shoujie Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer
Elisabeth Smolle et al.
MOLECULAR ONCOLOGY (2020)
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
Naama Wiesel-Motiuk et al.
DRUG RESISTANCE UPDATES (2020)
PFKP phenotype in lung cancer: prognostic potential and beyond
Shanmugasundaram Ganapathy-Kanniappan
MOLECULAR BIOLOGY REPORTS (2020)
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li et al.
DRUG RESISTANCE UPDATES (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elisabeth Perez-Ruiz et al.
DRUG RESISTANCE UPDATES (2020)
Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
Fabrizio Tabbo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies
Alberto D'Angelo et al.
CANCERS (2020)
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
Jiyeon Kim et al.
NATURE METABOLISM (2020)
Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy
Michael I. Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Targeting the RAS-dependent chemoresistance: The Warburg connection
Roberto Serna-Blasco et al.
SEMINARS IN CANCER BIOLOGY (2019)
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
Susmita Mondal et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer
Quanfu Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers
Morana Vojnic et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
YY1 regulates cancer cell immune resistance by modulating PD-L1 expression
Emily Hays et al.
DRUG RESISTANCE UPDATES (2019)
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
Alberto Cruz-Bermudez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival
Nadiia Lypova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
Edo Kon et al.
DRUG RESISTANCE UPDATES (2019)
Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer
Yanyang Cao et al.
CANCER CELL INTERNATIONAL (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Alessandro Leonetti et al.
DRUG RESISTANCE UPDATES (2019)
Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma
Xueying Yang et al.
FRONTIERS IN ONCOLOGY (2019)
The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
Karolien Vanhove et al.
FRONTIERS IN ONCOLOGY (2019)
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
Karolien Vanhove et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Gunnar Boysen et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells
Blair P. Curless et al.
INVESTIGATIONAL NEW DRUGS (2019)
Interconnection between Metabolism and Cell Cycle in Cancer
Philippe Icard et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
Jayshree Hirpara et al.
REDOX BIOLOGY (2019)
An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer
Xianan Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Targeting FBPase is an emerging novel approach for cancer therapy
Gao-Min Liu et al.
CANCER CELL INTERNATIONAL (2018)
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
Nicholas S. Akins et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
Thorsten Stiewe et al.
DRUG RESISTANCE UPDATES (2018)
Metabolic vulnerability of cisplatin-resistant cancers
Florine Obrist et al.
EMBO JOURNAL (2018)
Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
Yen-Hsiu Yeh et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
Tianxiao Gong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
Xiaoli Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
Yonathan Lissanu Deribe et al.
NATURE MEDICINE (2018)
Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer
Xiao Lu et al.
CANCER MANAGEMENT AND RESEARCH (2018)
EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis
Zineb Benbrahim et al.
BMC CANCER (2018)
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
Carlotta Granchi
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Zheng Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
Xiaodong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
The role of YAP/TAZ activity in cancer metabolic reprogramming
Xiaodong Zhang et al.
MOLECULAR CANCER (2018)
We're Not DON Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
Kathryn M. Lemberg et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Xiaoyue Zhao et al.
SCIENTIFIC REPORTS (2018)
MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
Alessandro Leonetti et al.
DRUG RESISTANCE UPDATES (2018)
IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5
Bingdi Yan et al.
OPEN BIOLOGY (2018)
T lymphocytes against solid malignancies: winning ways to defeat tumours
Ignazio Caruana et al.
CELL STRESS (2018)
The Warburg effect: persistence of stem-cell metabolism in cancers as a failure of differentiation
M. Riester et al.
ANNALS OF ONCOLOGY (2018)
Crystal structure of heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding
Robert B. Crochet et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2017)
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase
Steffi K. Koerner et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis
Alexandra Giatromanolaki et al.
EXPERIMENTAL LUNG RESEARCH (2017)
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Jiyeon Kim et al.
NATURE (2017)
A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma
Tuomas Tammela et al.
NATURE (2017)
O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect
Yang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
Jong-Ho Lee et al.
NATURE COMMUNICATIONS (2017)
Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras
Ken Peeters et al.
NATURE COMMUNICATIONS (2017)
Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies
Michael Yousef et al.
NUTRIENTS (2017)
Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC
Ling Li et al.
ONCOTARGET (2017)
Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
Jian-Guo Ren et al.
SCIENTIFIC REPORTS (2017)
Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism
Alexandra Giatromanolaki et al.
CANCER BIOLOGY & MEDICINE (2017)
Cancer metabolism: the volatile signature of glycolysis-in vitro model in lung cancer cells
Tali Feinberg et al.
JOURNAL OF BREATH RESEARCH (2017)
Targeting immunosuppressive adenosine in cancer (vol 17, pg 709, 2017)
Dipti Vijayan et al.
NATURE REVIEWS CANCER (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer
Bojana Ristic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges
Yael Diesendruck et al.
DRUG RESISTANCE UPDATES (2017)
Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening
Finith E. Jernigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation
Linglin Yu et al.
CANCER RESEARCH (2017)
Lipid metabolism and lung cancer
Maria Merino Salvador et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
Glutaminase 1 inhibition reduces thymidine synthesis in NSCLC
Jae-Seon Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines
Daniel R. Sappington et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Young Chan Chae et al.
CANCER CELL (2016)
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Seung-Oe Lim et al.
CANCER RESEARCH (2016)
Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer
Zoe Hall et al.
CANCER RESEARCH (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Wirginia Likus et al.
DRUG RESISTANCE UPDATES (2016)
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors
Seraina Faes et al.
MOLECULAR CANCER (2016)
Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis
Xinjian Li et al.
MOLECULAR CELL (2016)
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Robert U. Svensson et al.
NATURE MEDICINE (2016)
A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer
Y. Ma et al.
ONCOGENE (2016)
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
Jae-Seon Lee et al.
CELL DEATH & DISEASE (2016)
A key role for transketolase-like 1 in tumor metabolic reprogramming
Santiago Diaz-Moralli et al.
ONCOTARGET (2016)
A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis
Ming Chao et al.
eLife (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
Xiang Wang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
Alex J. Bott et al.
CELL METABOLISM (2015)
Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
Sophie Taylor et al.
DRUG RESISTANCE UPDATES (2015)
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors
Michael Juchum et al.
DRUG RESISTANCE UPDATES (2015)
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Elena Enzo et al.
EMBO JOURNAL (2015)
The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer
Yan-Wei Yin et al.
GENE EXPRESSION (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation
Xiang Zhou et al.
MOLECULAR CANCER (2015)
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer
Gorjan Hrustanovic et al.
NATURE MEDICINE (2015)
PTEN and PI3K/AKT in non-small-cell lung cancer
Cristina Perez-Ramirez et al.
PHARMACOGENOMICS (2015)
Pyruvate kinase: Function, regulation and role in cancer
William J. Israelsen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer
Moloy T. Goswami et al.
ONCOTARGET (2015)
Protein Prenylation: Enzymes, Therapeutics, and Biotechnology Applications
Charuta C. Palsuledesai et al.
ACS CHEMICAL BIOLOGY (2015)
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
Matteo Curtarello et al.
CANCER RESEARCH (2015)
How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?
H. Lincet et al.
ONCOGENE (2015)
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
Elizabeth J. Sullivan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth
Yajuan Gao et al.
CANCER LETTERS (2014)
Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption
Manuel Chan et al.
CANCER RESEARCH (2014)
PGE2-Driven Expression of c-Myc and OncomiR-17-92 Contributes to Apoptosis Resistance in NSCLC
Kostyantyn Krysan et al.
MOLECULAR CANCER RESEARCH (2014)
Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport
Chendong Yang et al.
MOLECULAR CELL (2014)
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
Lenaig Mescam-Mancini et al.
LUNG CANCER (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Monocarboxylate Transporters 1-4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Marte Eilertsen et al.
PLOS ONE (2014)
Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest
S. Raz et al.
CELL DEATH & DISEASE (2014)
6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
A. Yalcin et al.
CELL DEATH & DISEASE (2014)
Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
Laura Brunelli et al.
ONCOTARGET (2014)
Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRASG12D-driven lung tumors
Jessie Yanxiang Guo et al.
AUTOPHAGY (2013)
Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway
Alexis B. Cortot et al.
CANCER RESEARCH (2013)
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Brandon Faubert et al.
CELL METABOLISM (2013)
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Laura Soucek et al.
GENES & DEVELOPMENT (2013)
Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin
Laurent Schwartz et al.
INVESTIGATIONAL NEW DRUGS (2013)
Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression
Long Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2
Mohd Askandar Iqbal et al.
MOLECULAR CANCER (2013)
Acetylation Stabilizes ATP-Citrate Lyase to Promote Lipid Biosynthesis and Tumor Growth
Ruiting Lin et al.
MOLECULAR CELL (2013)
Mitogenic and Oncogenic Stimulation of K433 Acetylation Promotes PKM2 Protein Kinase Activity and Nuclear Localization
Lei Lv et al.
MOLECULAR CELL (2013)
Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle
Mahesh Saqcena et al.
PLOS ONE (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ATP citrate lyase knockdown impacts cancer stem cells in vitro
J-I Hanai et al.
CELL DEATH & DISEASE (2013)
Fulfilling the metabolic requirements for cell proliferation
Salvador Moncada et al.
BIOCHEMICAL JOURNAL (2012)
Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells
Vicky Goler-Baron et al.
BIOCHEMICAL PHARMACOLOGY (2012)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis
Yumin Hu et al.
CELL RESEARCH (2012)
Correction of Metabolic Acidosis with Potassium Citrate in Renal Transplant Patients and its Effect on Bone Quality
Astrid Starke et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
From tumor prevention to therapy: Empowering p53 to fight back
Christian Frezza et al.
DRUG RESISTANCE UPDATES (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
Availability, not respiratory capacity governs oxygen consumption of solid tumors
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation
Santanu Dasgupta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
Jun-ichi Hanai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis
Fengwei Tan et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Weiwei Yang et al.
NATURE CELL BIOLOGY (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Dimitrios Anastasiou et al.
NATURE CHEMICAL BIOLOGY (2012)
Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin
Mohd Askandar Iqbal et al.
PLOS ONE (2012)
HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR-Mutant Lung Cancers That Lack the Second-Site EGFRT790M Mutation
Ken Takezawa et al.
CANCER DISCOVERY (2012)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth
Lei Lv et al.
MOLECULAR CELL (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
Daniela Gaglio et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang et al.
NATURE (2011)
Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression
Gian Kayser et al.
PATHOLOGY (2011)
Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells
Sergio L. Colombo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
Marco Demaria et al.
AGING-US (2010)
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
Stephen Y. Lai et al.
DRUG RESISTANCE UPDATES (2010)
Clinical Relevance of KRAS in Human Cancers
Sylwia Jancik et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer
Scott A. Kono et al.
DRUG RESISTANCE UPDATES (2009)
HIF-1 alpha Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Alvaro Marin-Hernandez et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells
Steffen E. Schnitzer et al.
MOLECULAR CANCER RESEARCH (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Taro Hitosugi et al.
SCIENCE SIGNALING (2009)
ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
Toshiro Migita et al.
CANCER RESEARCH (2008)
Brick by brick: metabolism and tumor cell growth
Ralph J. DeBerardinis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate -: A possible role in Crabtree effect induction?
Rodrigo Diaz-Ruiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas
Esther Conde et al.
HUMAN PATHOLOGY (2007)
A pivotal role for p53: balancing aerobic respiration and glycolysis
Wenzhe Ma et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
Kirsty S. Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
ATP citrate lyase is an important component of cell growth and transformation
DE Bauer et al.
ONCOGENE (2005)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
DC Berwick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression
D D'Arcangelo et al.
CIRCULATION RESEARCH (2000)
Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins
R Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
